Skip to Main Content

Paper Details

Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy.
Clin Cancer Res
13
2022

Datasets

Release 1.2